Global Biochips Market By Type (DNA microarray, Lab On chip, Microfluid chip, Protein microarray) By Fabrication (Microarrays, Microfluids) By Application (Drug Discovery and development, Genomics, Cellomics, Proteomics, Disease Diagnostics, Others) By End Users (Hospitals and Clinics, Specialty Clinics, Biotech and Pharma Companies, Academic and Research Centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The newest element of this technological revolution to reach every corner of the world and benefit people from all walks of life is the biochip. A biochip is a miniature computer chip that combines electronic circuitry for electrical signal analysis with minute passageways for the transportation of fluids, often bodily fluids like blood. The ongoing trend in technology toward automation and miniaturisation led to the creation of biochips. Benchtop, heavy laboratory equipment was gradually reduced in size and packed into ever-tinier places as a result. Due to this, biochips are now used as miniature factories for mass production, with each chip having the capacity to hold multiple biochemical reaction simultaneously. Every year, at least 6 million medical devices are placed in patients, including breast implants, chin implants, and other prosthetic devices. And the majority of these medical equipment are equipped with a biochip as a vital part. Biochips are expected to have an increasing impact on genetic diagnostics, drug discovery, and fundamental research applications because they already have goods on the market. Biochips are being utilized in toxicological, protein, and biochemical studies, in addition to genetic applications that mainly analysed genetic material for flaws or sequence variants. With recent advancements in biochip technologies that link next-generation sequencing (NGS) to practical problems that have sparked scientific and medical advances, the market for biochips is expanding. The key advantages of biochips are their scalability and efficiency because they have been employed in sequencing technologies themselves, which is propelling the biochips market. Through the benefits of biochips, NGS has permitted revolutionary scientific discoveries and technological advances in medicine.
In terms of revenue, global biochips market was valued at US$ 18.02 Bn in 2021 growing at a CAGR of 25.4% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Biochips Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
Based on type, the global biochip market is segmented into DNA microarray, lab on chip, protein microarray. Lab on chip are widely being commercialized for some key applications such as glucose monitoring, HIV detection or heart attack diagnostics. The core of the lab-on-a-chip concept is the integration of thousands of biochemical operations that might be performed by splitting a single drop of patient blood to provide an accurate diagnostic of potential diseases. In the last few years, leading players in the market are incorporating advanced technologies into lab on chips. For instance, in a near future, lab-on-a-chip technologies, with their potential to do entire diagnosis of a patient at the period of a consultation, will transform the style of practising medicine. People with less training will perform the diagnosis, freeing professionals to concentrate solely on the therapy. Real-time diagnosis will improve patients' chances of surviving in emergency services and enable each patient to receive the right care. Thus with technological advancements into various types of chips, the global biochips market is expected to flourish in the upcoming years.
Application Outlook
Pharmacogenomics, biochemistry, proteology, microbiology, clinical pathology, and DNA analysis all have access to biochip technology. Biochips can be utilised for drug discovery and development, as well as screening analytes for signs of biological warfare. This can be done to diagnose molecular disorders and other illnesses, to provide individualised medical care, and to generally identify a variety of biomolecules in certain applications. Skin-on-a-chip applications also make more use of biochips. Biomedical and biotechnological research is where biochips are predominantly used. Proteomics biochips like microarrays are now more frequently used as medical technology progresses. Low sample requirements and a propensity for downsizing are two benefits of protein biochips. For instance, protein microarrays can process hundreds of samples simultaneously since they can display several proteins continually.
End Users Outlook
Based on the end user segment, the global biochips market is segmented into hospitals and clinics, specialty clinics, biotech and pharma companies, academic and research centers and others. Research centres and biotech companies are widely using biochips to study various fluids causing rare diseases. In the last few years, as there is an increased demand for personalized medicine biochips are widely being used for research. Moreover this technology has the potential to be a vital and potent tool for clinical research, diagnostics, drug development, toxicological investigations, and patient selection for clinical trials because of the advantages of low cost, high throughput, and miniaturisation. Thus due to its various advantages the global biochips market is expecting a huge growth in the upcoming years.
Region Outlook
Based on the regions, North America had the highest share in the biochips market in the year 2021. The region's dominant position is a result of the rapidly expanding usage of personalised medicine, the use of biochips, particularly for the discovery of new medications, and the development of biochip technology. Additionally, it is anticipated that increased income for North America would be brought about by government policies that support precision medicine together with significant investment in R&D for cancer genomes, the human proteome, etc. Furthermore due to the presence of leading players in the region and advanced healthcare facilities had boosted the growth of biochips market in the North America region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global biochips market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global biochips market are listed below:
- Agilent Technologies, Inc.
- BIOMÉRIEUX
- Bio-Rad Laboratories, Inc.
- HORIBA
- Illumina, Inc
- Merck KGaA
- Micronit B.V.
- PerkinElmer Inc
- Randox Laboratories Ltd.
- Rossetta Genomics LTD.
- Sengenics
- Other Industry Participants.
Global Biochips Market
By Type
- DNA microarray
- Lab On chip / Microfluid chip
- Protein microarray
By Fabrication
- Microarrays
- Microfluids
By Application
- Drug Discovery and development
- Disease Diagnostics
- Genomics
- Cellomics
- Proteomics
- Others
By End Users
- Hospitals and Clinics
- Specialty Clinics
- Biotech and Pharma Companies
- Academic and Research Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1.
Market
Segmentation
1.2.
Years
Considered
1.2.1.
Historic
Years: 2015 - 2020
1.2.2.
Base
Year: 2021
1.2.3.
Forecast
Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1.
Primary
Research
3.1.1.
Research
Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2.
Secondary
Research
3.2.1.
Paid
Databases
3.2.2.
Secondary
Sources
3.3.
Market
Size Estimates
3.3.1.
Top-Down
Approach
3.3.2.
Bottom-Up
Approach
3.4.
Data
Triangulation Methodology
3.5.
Research
Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Biochips Market
6.
Market
Synopsis: Biochips Market
7.
Biochips
Market Analysis: Qualitative Perspective
7.1.
Introduction
7.1.1.
Product
Definition
7.1.2.
Industry
Development
7.2.
Market
Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3.
Trends
in Biochips Market
7.4.
Market
Determinants Radar Chart
7.5.
Macro-Economic
and Micro-Economic Indicators: Biochips Market
7.6.
Porter’s
Five Force Analysis
7.7.
Impact
of Covid-19 on Biochips Market
8.
Global
Biochips Market Analysis and Forecasts, 2022 – 2030
8.1.
Overview
8.1.1.
Global
Biochips Market Revenue (US$ Mn)
8.2.
Global
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1.
DNA
microarray
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2.
Lab On
chip / microfluidic
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 – 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.2.3.
Protein
microarray
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 – 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 – 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 – 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 – 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 – 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 – 2030
8.3.
Key
Segment for Channeling Investments
8.3.1.
By Type
9.
Global
Biochips Market Analysis and Forecasts, 2022 – 2030
9.1.
Overview
9.2.
Global
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
9.2.1.
Microarrays
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2.
Microfluids
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.3.
Key
Segment for Channeling Investments
9.3.1.
By Fabrication
10. Global Biochips Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Biochips Market Revenue (US$ Mn) and
Forecasts, By Application
10.2.1. Drug Discovery and development
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 – 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Disease Diagnostics
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 – 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Genomics
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 – 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Cellomics
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 – 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Proteomics
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 – 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Others
10.2.6.1.
Definition
10.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.6.3.
Market
Forecast, 2022 – 2030
10.2.6.4.
Compound
Annual Growth Rate (CAGR)
10.2.6.5.
Regional
Bifurcation
10.2.6.5.1.
North
America
10.2.6.5.1.1. Market Estimation, 2015 - 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2.
Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3.
Asia
Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4.
Middle
East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5.
Latin
America
10.2.6.5.5.1. Market Estimation, 2015 - 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Biochips Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Biochips Market Revenue (US$ Mn) and
Forecasts, By End Users
11.2.1. Hospitals and Clinics
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 – 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Specialty Clinics
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 – 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Biotech and Pharma Companies
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 – 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Academic and Research Centers
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 – 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.2.5. Others
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.5.3.
Market
Forecast, 2022 – 2030
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2015 - 2021
11.2.5.5.1.2. Market Forecast, 2022 – 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2021
11.2.5.5.2.2. Market Forecast, 2022 – 2030
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2021
11.2.5.5.3.2. Market Forecast, 2022 – 2030
11.2.5.5.4.
Middle
East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2021
11.2.5.5.4.2. Market Forecast, 2022 – 2030
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2015 - 2021
11.2.5.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Biochips Market Analysis and
Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Biochips Market Revenue (US$
Mn)
12.2. North America Biochips Market Revenue (US$
Mn) and Forecasts, By Type
12.2.1. DNA microarray
12.2.2. Lab On chip / microfluidic
12.2.3. Protein microarray
12.3. North America Biochips Market Revenue (US$
Mn) and Forecasts, By Fabrication
12.3.1. Microarrays
12.3.2. Microfluids
12.4. North America Biochips Market Revenue (US$
Mn) and Forecasts, By Application
12.4.1. Drug Discovery and development
12.4.2. Disease Diagnostics
12.4.3. Genomics
12.4.4. Cellomics
12.4.5. Proteomics
12.4.6. Others
12.5. North America Biochips Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.1. Hospitals and Clinics
12.5.2. Specialty Clinics
12.5.3. Biotech and Pharma Companies
12.5.4. Academic and Research Centers
12.5.5. Others
12.6. North America Biochips Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
12.6.1.1.1.
DNA
microarray
12.6.1.1.2.
Lab On
chip / microfluidic
12.6.1.1.3.
Protein
microarray
12.6.1.2.
U.S
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
12.6.1.2.1.
Microarrays
12.6.1.2.2.
Microfluids
12.6.1.3.
U.S
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.3.1.
Drug
Discovery and development
12.6.1.3.2.
Disease
Diagnostics
12.6.1.3.3.
Genomics
12.6.1.3.4.
Cellomics
12.6.1.3.5.
Proteomics
12.6.1.3.6.
Others
12.6.1.4.
U.S
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1.
Hospitals
and Clinics
12.6.1.4.2.
Specialty
Clinics
12.6.1.4.3.
Biotech
and Pharma Companies
12.6.1.4.4.
Academic
and Research Centers
12.6.1.4.5.
Others
12.6.2. Canada
12.6.2.1.
Canada
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.1.1.
DNA
microarray
12.6.2.1.2.
Lab On
chip / microfluidic
12.6.2.1.3.
Protein
microarray
12.6.2.2.
Canada
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
12.6.2.2.1.
Microarrays
12.6.2.2.2.
Microfluids
12.6.2.3.
Canada
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.3.1.
Drug
Discovery and development
12.6.2.3.2.
Disease
Diagnostics
12.6.2.3.3.
Genomics
12.6.2.3.4.
Cellomics
12.6.2.3.5.
Proteomics
12.6.2.3.6.
Others
12.6.2.4.
Canada
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1.
Hospitals
and Clinics
12.6.2.4.2.
Specialty
Clinics
12.6.2.4.3.
Biotech
and Pharma Companies
12.6.2.4.4.
Academic
and Research Centers
12.6.2.4.5.
Others
12.6.3. Mexico
12.6.3.1.
Mexico
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
12.6.3.1.1.
DNA
microarray
12.6.3.1.2.
Lab On
chip / microfluidic
12.6.3.1.3.
Protein
microarray
12.6.3.2.
Mexico
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
12.6.3.2.1.
Microarrays
12.6.3.2.2.
Microfluids
12.6.3.3.
Mexico
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1.
Drug
Discovery and development
12.6.3.3.2.
Disease
Diagnostics
12.6.3.3.3.
Genomics
12.6.3.3.4.
Cellomics
12.6.3.3.5.
Proteomics
12.6.3.3.6.
Others
12.6.3.4.
Mexico
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1.
Hospitals
and Clinics
12.6.3.4.2.
Specialty
Clinics
12.6.3.4.3.
Biotech
and Pharma Companies
12.6.3.4.4.
Academic
and Research Centers
12.6.3.4.5.
Others
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Biochips Market Revenue (US$ Mn) and Forecasts, By Type
12.6.4.1.1.
DNA
microarray
12.6.4.1.2.
Lab On
chip / microfluidic
12.6.4.1.3.
Protein
microarray
12.6.4.2.
Rest of
North America Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
12.6.4.2.1.
Microarrays
12.6.4.2.2.
Microfluids
12.6.4.3.
Rest of
North America Biochips Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1.
Drug
Discovery and development
12.6.4.3.2.
Disease
Diagnostics
12.6.4.3.3.
Genomics
12.6.4.3.4.
Cellomics
12.6.4.3.5.
Proteomics
12.6.4.3.6.
Others
12.6.4.4.
Rest of
North America Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1.
Hospitals
and Clinics
12.6.4.4.2.
Specialty
Clinics
12.6.4.4.3.
Biotech
and Pharma Companies
12.6.4.4.4.
Academic
and Research Centers
12.6.4.4.5.
Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Type
12.7.3. By
Fabrication
12.7.4. By Application
12.7.5. By End Users
13. Europe Biochips Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Biochips Market Revenue (US$ Mn)
13.2. Europe Biochips Market Revenue (US$ Mn) and
Forecasts, By Type
13.2.1. DNA microarray
13.2.2. Lab On chip / microfluidic
13.2.3. Protein microarray
13.3. Europe Biochips Market Revenue (US$ Mn) and
Forecasts, By Fabrication
13.3.1. Microarrays
13.3.2. Microfluids
13.4. Europe Biochips Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1. Drug Discovery and development
13.4.2. Disease Diagnostics
13.4.3. Genomics
13.4.4. Cellomics
13.4.5. Proteomics
13.4.6. Others
13.5. Europe Biochips Market Revenue (US$ Mn) and
Forecasts, By End Users
13.5.1. Hospitals and Clinics
13.5.2. Specialty Clinics
13.5.3. Biotech and Pharma Companies
13.5.4. Academic and Research Centers
13.5.5. Others
13.6. Europe Biochips Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.1. France
13.6.1.1.
France
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.1.1.1.
DNA
microarray
13.6.1.1.2.
Lab On
chip / microfluidic
13.6.1.1.3.
Protein
microarray
13.6.1.2.
France
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.1.2.1.
Microarrays
13.6.1.2.2.
Microfluids
13.6.1.3.
France
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1.
Drug
Discovery and development
13.6.1.3.2.
Disease
Diagnostics
13.6.1.3.3.
Genomics
13.6.1.3.4.
Cellomics
13.6.1.3.5.
Proteomics
13.6.1.3.6.
Others
13.6.1.4.
France
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1.
Hospitals
and Clinics
13.6.1.4.2.
Specialty
Clinics
13.6.1.4.3.
Biotech
and Pharma Companies
13.6.1.4.4.
Academic
and Research Centers
13.6.1.4.5.
Others
13.6.2. The UK
13.6.2.1.
The UK
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.2.1.1.
DNA
microarray
13.6.2.1.2.
Lab On
chip / microfluidic
13.6.2.1.3.
Protein
microarray
13.6.2.2.
The UK
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.2.2.1.
Microarrays
13.6.2.2.2.
Microfluids
13.6.2.3.
The UK
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.3.1.
Drug
Discovery and development
13.6.2.3.2.
Disease
Diagnostics
13.6.2.3.3.
Genomics
13.6.2.3.4.
Cellomics
13.6.2.3.5.
Proteomics
13.6.2.3.6.
Others
13.6.2.4.
The UK
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1.
Hospitals
and Clinics
13.6.2.4.2.
Specialty
Clinics
13.6.2.4.3.
Biotech
and Pharma Companies
13.6.2.4.4.
Academic
and Research Centers
13.6.2.4.5.
Others
13.6.3. Spain
13.6.3.1.
Spain
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.3.1.1.
DNA
microarray
13.6.3.1.2.
Lab On
chip / microfluidic
13.6.3.1.3.
Protein
microarray
13.6.3.2.
Spain
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.3.2.1.
Microarrays
13.6.3.2.2.
Microfluids
13.6.3.3.
Spain
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.3.1.
Drug
Discovery and development
13.6.3.3.2.
Disease
Diagnostics
13.6.3.3.3.
Genomics
13.6.3.3.4.
Cellomics
13.6.3.3.5.
Proteomics
13.6.3.3.6.
Others
13.6.3.4.
Spain
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.4.1.
Hospitals
and Clinics
13.6.3.4.2.
Specialty
Clinics
13.6.3.4.3.
Biotech
and Pharma Companies
13.6.3.4.4.
Academic
and Research Centers
13.6.3.4.5.
Others
13.6.4. Germany
13.6.4.1.
Germany
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.4.1.1.
DNA microarray
13.6.4.1.2.
Lab On
chip / microfluidic
13.6.4.1.3.
Protein
microarray
13.6.4.2.
Germany
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.4.2.1.
Microarrays
13.6.4.2.2.
Microfluids
13.6.4.3.
Germany
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.3.1.
Drug
Discovery and development
13.6.4.3.2.
Disease
Diagnostics
13.6.4.3.3.
Genomics
13.6.4.3.4.
Cellomics
13.6.4.3.5.
Proteomics
13.6.4.3.6.
Others
13.6.4.4.
Germany
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1.
Hospitals
and Clinics
13.6.4.4.2.
Specialty
Clinics
13.6.4.4.3.
Biotech
and Pharma Companies
13.6.4.4.4.
Academic
and Research Centers
13.6.4.4.5.
Others
13.6.5. Italy
13.6.5.1.
Italy
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.5.1.1.
DNA
microarray
13.6.5.1.2.
Lab On
chip / microfluidic
13.6.5.1.3.
Protein
microarray
13.6.5.2.
Italy
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.5.2.1.
Microarrays
13.6.5.2.2.
Microfluids
13.6.5.3.
Italy
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.3.1.
Drug
Discovery and development
13.6.5.3.2.
Disease
Diagnostics
13.6.5.3.3.
Genomics
13.6.5.3.4.
Cellomics
13.6.5.3.5.
Proteomics
13.6.5.3.6.
Others
13.6.5.4.
Italy
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1.
Hospitals
and Clinics
13.6.5.4.2.
Specialty
Clinics
13.6.5.4.3.
Biotech
and Pharma Companies
13.6.5.4.4.
Academic
and Research Centers
13.6.5.4.5.
Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.6.1.1.
DNA
microarray
13.6.6.1.2.
Lab On
chip / microfluidic
13.6.6.1.3.
Protein
microarray
13.6.6.2.
Nordic
Countries Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.6.2.1.
Microarrays
13.6.6.2.2.
Microfluids
13.6.6.3.
Nordic
Countries Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1.
Drug
Discovery and development
13.6.6.3.2.
Disease
Diagnostics
13.6.6.3.3.
Genomics
13.6.6.3.4.
Cellomics
13.6.6.3.5.
Proteomics
13.6.6.3.6.
Others
13.6.6.4.
Nordic
Countries Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1.
Hospitals
and Clinics
13.6.6.4.2.
Specialty
Clinics
13.6.6.4.3.
Biotech
and Pharma Companies
13.6.6.4.4.
Academic
and Research Centers
13.6.6.4.5.
Others
13.6.6.5.
Nordic
Countries Biochips Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.7.1.1.
DNA
microarray
13.6.7.1.2.
Lab On
chip / microfluidic
13.6.7.1.3.
Protein
microarray
13.6.7.2.
Benelux
Union Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.7.2.1.
Microarrays
13.6.7.2.2.
Microfluids
13.6.7.3.
Benelux
Union Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1.
Drug
Discovery and development
13.6.7.3.2.
Disease
Diagnostics
13.6.7.3.3.
Genomics
13.6.7.3.4.
Cellomics
13.6.7.3.5.
Proteomics
13.6.7.3.6.
Others
13.6.7.4.
Benelux
Union Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1.
Hospitals
and Clinics
13.6.7.4.2.
Specialty
Clinics
13.6.7.4.3.
Biotech
and Pharma Companies
13.6.7.4.4.
Academic
and Research Centers
13.6.7.4.5.
Others
13.6.7.5.
Benelux
Union Biochips Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Biochips Market Revenue (US$ Mn) and Forecasts, By Type
13.6.8.1.1.
DNA
microarray
13.6.8.1.2.
Lab On
chip / microfluidic
13.6.8.1.3.
Protein
microarray
13.6.8.2.
Rest of
Europe Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
13.6.8.2.1.
Microarrays
13.6.8.2.2.
Microfluids
13.6.8.3.
Rest of
Europe Biochips Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1.
Drug
Discovery and development
13.6.8.3.2.
Disease
Diagnostics
13.6.8.3.3.
Genomics
13.6.8.3.4.
Cellomics
13.6.8.3.5.
Proteomics
13.6.8.3.6.
Others
13.6.8.4.
Rest of
Europe Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1.
Hospitals
and Clinics
13.6.8.4.2.
Specialty
Clinics
13.6.8.4.3.
Biotech
and Pharma Companies
13.6.8.4.4.
Academic
and Research Centers
13.6.8.4.5.
Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Type
13.7.3. By
Fabrication
13.7.4. By Application
13.7.5. By End Users
14. Asia Pacific Biochips Market Analysis and
Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Biochips Market Revenue (US$ Mn)
14.2. Asia Pacific Biochips Market Revenue (US$ Mn)
and Forecasts, By Type
14.2.1. DNA microarray
14.2.2. Lab On chip / microfluidic
14.2.3. Protein microarray
14.3. Asia Pacific Biochips Market Revenue (US$ Mn)
and Forecasts, By Fabrication
14.3.1. Microarrays
14.3.2. Microfluids
14.4. Asia Pacific Biochips Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.1. Drug Discovery and development
14.4.2. Disease Diagnostics
14.4.3. Genomics
14.4.4. Cellomics
14.4.5. Proteomics
14.4.6. Others
14.5. Asia Pacific Biochips Market Revenue (US$ Mn)
and Forecasts, By End Users
14.5.1. Hospitals and Clinics
14.5.2. Specialty Clinics
14.5.3. Biotech and Pharma Companies
14.5.4. Academic and Research Centers
14.5.5. Others
14.6. Asia Pacific Biochips Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.1. China
14.6.1.1.
China
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.1.1.1.
DNA
microarray
14.6.1.1.2.
Lab On
chip / microfluidic
14.6.1.1.3.
Protein
microarray
14.6.1.2.
China
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.1.2.1.
Microarrays
14.6.1.2.2.
Microfluids
14.6.1.3.
China
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.3.1.
Drug
Discovery and development
14.6.1.3.2.
Disease
Diagnostics
14.6.1.3.3.
Genomics
14.6.1.3.4.
Cellomics
14.6.1.3.5.
Proteomics
14.6.1.3.6.
Others
14.6.1.4.
China
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1.
Hospitals
and Clinics
14.6.1.4.2.
Specialty
Clinics
14.6.1.4.3.
Biotech
and Pharma Companies
14.6.1.4.4.
Academic
and Research Centers
14.6.1.4.5.
Others
14.6.2. Japan
14.6.2.1.
Japan
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.2.1.1.
DNA
microarray
14.6.2.1.2.
Lab On
chip / microfluidic
14.6.2.1.3.
Protein
microarray
14.6.2.2.
Japan
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.2.2.1.
Microarrays
14.6.2.2.2.
Microfluids
14.6.2.3.
Japan
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.3.1.
Drug
Discovery and development
14.6.2.3.2.
Disease Diagnostics
14.6.2.3.3.
Genomics
14.6.2.3.4.
Cellomics
14.6.2.3.5.
Proteomics
14.6.2.3.6.
Others
14.6.2.4.
Japan
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1.
Hospitals
and Clinics
14.6.2.4.2.
Specialty
Clinics
14.6.2.4.3.
Biotech
and Pharma Companies
14.6.2.4.4.
Academic
and Research Centers
14.6.2.4.5.
Others
14.6.3. India
14.6.3.1.
India
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.3.1.1.
DNA
microarray
14.6.3.1.2.
Lab On
chip / microfluidic
14.6.3.1.3.
Protein
microarray
14.6.3.2.
India
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.3.2.1.
Microarrays
14.6.3.2.2.
Microfluids
14.6.3.3.
India
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.3.1.
Drug
Discovery and development
14.6.3.3.2.
Disease
Diagnostics
14.6.3.3.3.
Genomics
14.6.3.3.4.
Cellomics
14.6.3.3.5.
Proteomics
14.6.3.3.6.
Others
14.6.3.4.
India
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1.
Hospitals
and Clinics
14.6.3.4.2.
Specialty
Clinics
14.6.3.4.3.
Biotech
and Pharma Companies
14.6.3.4.4.
Academic
and Research Centers
14.6.3.4.5.
Others
14.6.4. New Zealand
14.6.4.1.
New
Zealand Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.4.1.1.
DNA
microarray
14.6.4.1.2.
Lab On
chip / microfluidic
14.6.4.1.3.
Protein
microarray
14.6.4.2.
New
Zealand Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.4.2.1.
Microarrays
14.6.4.2.2.
Microfluids
14.6.4.3.
New
Zealand Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.3.1.
Drug
Discovery and development
14.6.4.3.2.
Disease
Diagnostics
14.6.4.3.3.
Genomics
14.6.4.3.4.
Cellomics
14.6.4.3.5.
Proteomics
14.6.4.3.6.
Others
14.6.4.4.
New
Zealand Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1.
Hospitals
and Clinics
14.6.4.4.2.
Specialty
Clinics
14.6.4.4.3.
Biotech
and Pharma Companies
14.6.4.4.4.
Academic
and Research Centers
14.6.4.4.5.
Others
14.6.5. Australia
14.6.5.1.
Australia
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.5.1.1.
DNA
microarray
14.6.5.1.2.
Lab On
chip / microfluidic
14.6.5.1.3.
Protein
microarray
14.6.5.2.
Australia
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.5.2.1.
Microarrays
14.6.5.2.2.
Microfluids
14.6.5.3.
Australia
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.3.1.
Drug
Discovery and development
14.6.5.3.2.
Disease
Diagnostics
14.6.5.3.3.
Genomics
14.6.5.3.4.
Cellomics
14.6.5.3.5.
Proteomics
14.6.5.3.6.
Others
14.6.5.4.
Australia
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1.
Hospitals
and Clinics
14.6.5.4.2.
Specialty
Clinics
14.6.5.4.3.
Biotech
and Pharma Companies
14.6.5.4.4.
Academic
and Research Centers
14.6.5.4.5.
Others
14.6.6. South Korea
14.6.6.1.
South
Korea Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.6.1.1.
DNA
microarray
14.6.6.1.2.
Lab On
chip / microfluidic
14.6.6.1.3.
Protein
microarray
14.6.6.2.
South
Korea Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.6.2.1.
Microarrays
14.6.6.2.2.
Microfluids
14.6.6.3.
South
Korea Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1.
Drug
Discovery and development
14.6.6.3.2.
Disease
Diagnostics
14.6.6.3.3.
Genomics
14.6.6.3.4.
Cellomics
14.6.6.3.5.
Proteomics
14.6.6.3.6.
Others
14.6.6.4.
South
Korea Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1.
Hospitals
and Clinics
14.6.6.4.2.
Specialty
Clinics
14.6.6.4.3.
Biotech
and Pharma Companies
14.6.6.4.4.
Academic
and Research Centers
14.6.6.4.5.
Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.7.1.1.
DNA
microarray
14.6.7.1.2.
Lab On
chip / microfluidic
14.6.7.1.3.
Protein
microarray
14.6.7.2.
Southeast
Asia Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.7.2.1.
Microarrays
14.6.7.2.2.
Microfluids
14.6.7.3.
Southeast
Asia Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1.
Drug
Discovery and development
14.6.7.3.2.
Disease
Diagnostics
14.6.7.3.3.
Genomics
14.6.7.3.4.
Cellomics
14.6.7.3.5.
Proteomics
14.6.7.3.6.
Others
14.6.7.4.
Southeast
Asia Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1.
Hospitals
and Clinics
14.6.7.4.2.
Specialty
Clinics
14.6.7.4.3.
Biotech
and Pharma Companies
14.6.7.4.4.
Academic
and Research Centers
14.6.7.4.5.
Others
14.6.7.5.
Southeast
Asia Biochips Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Biochips Market Revenue (US$ Mn) and Forecasts, By Type
14.6.8.1.1.
DNA
microarray
14.6.8.1.2.
Lab On
chip / microfluidic
14.6.8.1.3.
Protein
microarray
14.6.8.2.
Rest of
Asia Pacific Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
14.6.8.2.1.
Microarrays
14.6.8.2.2.
Microfluids
14.6.8.3.
Rest of
Asia Pacific Biochips Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1.
Drug
Discovery and development
14.6.8.3.2.
Disease
Diagnostics
14.6.8.3.3.
Genomics
14.6.8.3.4.
Cellomics
14.6.8.3.5.
Proteomics
14.6.8.3.6.
Others
14.6.8.4.
Rest of
Asia Pacific Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1.
Hospitals
and Clinics
14.6.8.4.2.
Specialty
Clinics
14.6.8.4.3.
Biotech
and Pharma Companies
14.6.8.4.4.
Academic
and Research Centers
14.6.8.4.5.
Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Type
14.7.3. By
Fabrication
14.7.4. By Application
14.7.5. By End Users
15. Middle East and Africa Biochips Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Biochips Market
Revenue (US$ Mn)
15.2. Middle East and Africa Biochips Market
Revenue (US$ Mn) and Forecasts, By Type
15.2.1. DNA microarray
15.2.2. Lab On chip / microfluidic
15.2.3. Protein microarray
15.3. Middle East and Africa Biochips Market
Revenue (US$ Mn) and Forecasts, By
Fabrication
15.3.1. Microarrays
15.3.2. Microfluids
15.4. Middle East and Africa Biochips Market
Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Drug Discovery and development
15.4.2. Disease Diagnostics
15.4.3. Genomics
15.4.4. Cellomics
15.4.5. Proteomics
15.4.6. Others
15.5. Middle East and Africa Biochips Market
Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Hospitals and Clinics
15.5.2. Specialty Clinics
15.5.3. Biotech and Pharma Companies
15.5.4. Academic and Research Centers
15.5.5. Others
15.6. Middle East and Africa Biochips Market
Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Biochips Market Revenue (US$ Mn) and Forecasts, By Type
15.6.1.1.1.
DNA microarray
15.6.1.1.2.
Lab On
chip / microfluidic
15.6.1.1.3.
Protein
microarray
15.6.1.2.
Saudi
Arabia Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
15.6.1.2.1.
Microarrays
15.6.1.2.2.
Microfluids
15.6.1.3.
Saudi
Arabia Biochips Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1.
Drug
Discovery and development
15.6.1.3.2.
Disease
Diagnostics
15.6.1.3.3.
Genomics
15.6.1.3.4.
Cellomics
15.6.1.3.5.
Proteomics
15.6.1.3.6.
Others
15.6.1.4.
Saudi
Arabia Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1.
Hospitals
and Clinics
15.6.1.4.2.
Specialty
Clinics
15.6.1.4.3.
Biotech
and Pharma Companies
15.6.1.4.4.
Academic
and Research Centers
15.6.1.4.5.
Others
15.6.2. UAE
15.6.2.1.
UAE
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
15.6.2.1.1.
DNA
microarray
15.6.2.1.2.
Lab On
chip / microfluidic
15.6.2.1.3.
Protein
microarray
15.6.2.2.
UAE
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
15.6.2.2.1.
Microarrays
15.6.2.2.2.
Microfluids
15.6.2.3.
UAE
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1.
Drug
Discovery and development
15.6.2.3.2.
Disease
Diagnostics
15.6.2.3.3.
Genomics
15.6.2.3.4.
Cellomics
15.6.2.3.5.
Proteomics
15.6.2.3.6.
Others
15.6.2.4.
UAE
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1.
Hospitals
and Clinics
15.6.2.4.2.
Specialty
Clinics
15.6.2.4.3.
Biotech
and Pharma Companies
15.6.2.4.4.
Academic
and Research Centers
15.6.2.4.5.
Others
15.6.3. Egypt
15.6.3.1.
Egypt
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
15.6.3.1.1.
DNA
microarray
15.6.3.1.2.
Lab On
chip / microfluidic
15.6.3.1.3.
Protein
microarray
15.6.3.2.
Egypt
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
15.6.3.2.1.
Microarrays
15.6.3.2.2.
Microfluids
15.6.3.3.
Egypt
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.3.1.
Drug
Discovery and development
15.6.3.3.2.
Disease
Diagnostics
15.6.3.3.3.
Genomics
15.6.3.3.4.
Cellomics
15.6.3.3.5.
Proteomics
15.6.3.3.6.
Others
15.6.3.4.
Egypt
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1.
Hospitals
and Clinics
15.6.3.4.2.
Specialty
Clinics
15.6.3.4.3.
Biotech
and Pharma Companies
15.6.3.4.4.
Academic
and Research Centers
15.6.3.4.5.
Others
15.6.4. Kuwait
15.6.4.1.
Kuwait
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
15.6.4.1.1.
DNA
microarray
15.6.4.1.2.
Lab On
chip / microfluidic
15.6.4.1.3.
Protein
microarray
15.6.4.2.
Kuwait
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
15.6.4.2.1.
Microarrays
15.6.4.2.2.
Microfluids
15.6.4.3.
Kuwait
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.3.1.
Drug
Discovery and development
15.6.4.3.2.
Disease
Diagnostics
15.6.4.3.3.
Genomics
15.6.4.3.4.
Cellomics
15.6.4.3.5.
Proteomics
15.6.4.3.6.
Others
15.6.4.4.
Kuwait
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1.
Hospitals
and Clinics
15.6.4.4.2.
Specialty
Clinics
15.6.4.4.3.
Biotech
and Pharma Companies
15.6.4.4.4.
Academic
and Research Centers
15.6.4.4.5.
Others
15.6.5. South Africa
15.6.5.1.
South
Africa Biochips Market Revenue (US$ Mn) and Forecasts, By Type
15.6.5.1.1.
DNA
microarray
15.6.5.1.2.
Lab On
chip / microfluidic
15.6.5.1.3.
Protein
microarray
15.6.5.2.
South
Africa Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
15.6.5.2.1.
Microarrays
15.6.5.2.2.
Microfluids
15.6.5.3.
South
Africa Biochips Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.3.1.
Drug
Discovery and development
15.6.5.3.2.
Disease
Diagnostics
15.6.5.3.3.
Genomics
15.6.5.3.4.
Cellomics
15.6.5.3.5.
Proteomics
15.6.5.3.6.
Others
15.6.5.4.
South
Africa Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1.
Hospitals
and Clinics
15.6.5.4.2.
Specialty
Clinics
15.6.5.4.3.
Biotech
and Pharma Companies
15.6.5.4.4.
Academic
and Research Centers
15.6.5.4.5.
Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Biochips Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.6.1.1.
DNA
microarray
15.6.6.1.2.
Lab On
chip / microfluidic
15.6.6.1.3.
Protein
microarray
15.6.6.2.
Rest of
Middle East & Africa Biochips Market Revenue (US$ Mn) and Forecasts,
By Fabrication
15.6.6.2.1.
Microarrays
15.6.6.2.2.
Microfluids
15.6.6.3.
Rest of
Middle East & Africa Biochips Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.6.3.1.
Drug
Discovery and development
15.6.6.3.2.
Disease
Diagnostics
15.6.6.3.3.
Genomics
15.6.6.3.4.
Cellomics
15.6.6.3.5.
Proteomics
15.6.6.3.6.
Others
15.6.6.4.
Rest of
Middle East & Africa Biochips Market Revenue (US$ Mn) and Forecasts, By End
Users
15.6.6.4.1.
Hospitals
and Clinics
15.6.6.4.2.
Specialty
Clinics
15.6.6.4.3.
Biotech
and Pharma Companies
15.6.6.4.4.
Academic
and Research Centers
15.6.6.4.5.
Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Type
15.7.3. By
Fabrication
15.7.4. By Application
15.7.5. By End Users
16. Latin America Biochips Market Analysis and
Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Biochips Market Revenue (US$
Mn)
16.2. Latin America Biochips Market Revenue (US$
Mn) and Forecasts, By Type
16.2.1. DNA microarray
16.2.2. Lab On chip / microfluidic
16.2.3. Protein microarray
16.3. Latin America Biochips Market Revenue (US$
Mn) and Forecasts, By Fabrication
16.3.1. Microarrays
16.3.2. Microfluids
16.4. Latin America Biochips Market Revenue (US$
Mn) and Forecasts, By Application
16.4.1. Drug Discovery and development
16.4.2. Disease Diagnostics
16.4.3. Genomics
16.4.4. Cellomics
16.4.5. Proteomics
16.4.6. Others
16.5. Latin America Biochips Market Revenue (US$
Mn) and Forecasts, By End Users
16.5.1. Hospitals and Clinics
16.5.2. Specialty Clinics
16.5.3. Biotech and Pharma Companies
16.5.4. Academic and Research Centers
16.5.5. Others
16.6. Latin America Biochips Market Revenue (US$
Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
16.6.1.1.1.
DNA
microarray
16.6.1.1.2.
Lab On
chip / microfluidic
16.6.1.1.3.
Protein
microarray
16.6.1.2.
Brazil
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
16.6.1.2.1.
Microarrays
16.6.1.2.2.
Microfluids
16.6.1.3.
Brazil
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.3.1.
Drug
Discovery and development
16.6.1.3.2.
Disease
Diagnostics
16.6.1.3.3.
Genomics
16.6.1.3.4.
Cellomics
16.6.1.3.5.
Proteomics
16.6.1.3.6.
Others
16.6.1.4.
Brazil
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1.
Hospitals
and Clinics
16.6.1.4.2.
Specialty
Clinics
16.6.1.4.3.
Biotech
and Pharma Companies
16.6.1.4.4.
Academic
and Research Centers
16.6.1.4.5.
Others
16.6.2. Argentina
16.6.2.1.
Argentina
Biochips Market Revenue (US$ Mn) and Forecasts, By Type
16.6.2.1.1.
DNA
microarray
16.6.2.1.2.
Lab On
chip / microfluidic
16.6.2.1.3.
Protein
microarray
16.6.2.2.
Argentina
Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
16.6.2.2.1.
Microarrays
16.6.2.2.2.
Microfluids
16.6.2.3.
Argentina
Biochips Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.3.1.
Drug
Discovery and development
16.6.2.3.2.
Disease
Diagnostics
16.6.2.3.3.
Genomics
16.6.2.3.4.
Cellomics
16.6.2.3.5.
Proteomics
16.6.2.3.6.
Others
16.6.2.4.
Argentina
Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1.
Hospitals
and Clinics
16.6.2.4.2.
Specialty
Clinics
16.6.2.4.3.
Biotech
and Pharma Companies
16.6.2.4.4.
Academic
and Research Centers
16.6.2.4.5.
Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Biochips Market Revenue (US$ Mn) and Forecasts, By Type
16.6.3.1.1.
DNA
microarray
16.6.3.1.2.
Lab On
chip / microfluidic
16.6.3.1.3.
Protein
microarray
16.6.3.2.
Rest of
Latin America Biochips Market Revenue (US$ Mn) and Forecasts, By Fabrication
16.6.3.2.1.
Microarrays
16.6.3.2.2.
Microfluids
16.6.3.3.
Rest of
Latin America Biochips Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1.
Drug
Discovery and development
16.6.3.3.2.
Disease
Diagnostics
16.6.3.3.3.
Genomics
16.6.3.3.4.
Cellomics
16.6.3.3.5.
Proteomics
16.6.3.3.6.
Others
16.6.3.4.
Rest of
Latin America Biochips Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1.
Hospitals
and Clinics
16.6.3.4.2.
Specialty
Clinics
16.6.3.4.3.
Biotech
and Pharma Companies
16.6.3.4.4.
Academic
and Research Centers
16.6.3.4.5.
Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Type
16.7.3. By
Fabrication
16.7.4. By Application
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2020
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Agilent Technologies, Inc.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. BIOMÉRIEUX
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Bio-Rad Laboratories, Inc.
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. HORIBA
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. Illumina, Inc
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Micronit B.V.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. PerkinElmer Inc
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Randox Laboratories Ltd.
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7.
Business
Strategies
18.9. Other Industry Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.